132.75
132.75 (0%)
As of May 29, 2025
BIOGEN INC. [BIIB]
Source:
Company Overview
Biogen is a global biopharmaceutical company focused on discovering, developing and delivering innovative therapies for people living with serious and complex diseases worldwide. We have a broad portfolio of medicines to treat multiple sclerosis (MS), have introduced the first approved treatment for spinal muscular atrophy (SMA) and co-developed two treatments to address a defining pathology of Alzheimer’s disease.
Country | United States |
Headquarters | cambridge, massachusetts |
Phone Number | (617) 679-2000 |
Industry | manufacturing |
CEO | Chris Viehbacher |
Website | biogen.com |